Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
WASHINGTON UNIVERSITY - DERMATOLOGY, 4921 Parkview Place
mi
from
Saint Louis, MO
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
WASHINGTON UNIVERSITY - DERMATOLOGY, 4921 Parkview Place
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
WASHINGTON UNIVERSITY - DERMATOLOGY, 969 Mason Road
mi
from
Saint Louis, MO
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
WASHINGTON UNIVERSITY - DERMATOLOGY, 969 Mason Road
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
ACTIVMED PRACTICES AND RESEARCH, INC, 110 Corporate Drive
mi
from
Portsmouth, NH
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
ACTIVMED PRACTICES AND RESEARCH, INC, 110 Corporate Drive
mi
from
Portsmouth, NH
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
HASSMAN RESEARCH INSTITUTE, LLC, 175 Cross Keys Road
mi
from
Berlin, NJ
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
HASSMAN RESEARCH INSTITUTE, LLC, 175 Cross Keys Road
mi
from
Berlin, NJ
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
DERMATOLOGY CONSULTING SERVICES, PLLC, 2444 North Main Street
mi
from
High Point, NC
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
DERMATOLOGY CONSULTING SERVICES, PLLC, 2444 North Main Street
mi
from
High Point, NC
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
WAKE RESEARCH ASSOCIATES LLC, 3100 Duraleigh Road
mi
from
Raleigh, NC
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
WAKE RESEARCH ASSOCIATES LLC, 3100 Duraleigh Road
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
DERMATOLOGISTS OF GREATER COLUMBUS, 2359 East Main Street
mi
from
Bexley, OH
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
DERMATOLOGISTS OF GREATER COLUMBUS, 2359 East Main Street
mi
from
Bexley, OH
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
RAPID MEDICAL RESEARCH, INC, 3619 Park East Drive
mi
from
Cleveland, OH
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
RAPID MEDICAL RESEARCH, INC, 3619 Park East Drive
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
CENTRAL SOONER RESEARCH, 900 North Porter
mi
from
Norman, OK
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
CENTRAL SOONER RESEARCH, 900 North Porter
mi
from
Norman, OK
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
PEAK RESEARCH LLC, 2589 Washington Rd
mi
from
Upper Saint Clair, PA
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
PEAK RESEARCH LLC, 2589 Washington Rd
mi
from
Upper Saint Clair, PA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
ARLINGTON RESEARCH CENTER, INC, 711 East Lamar Blvd
mi
from
Arlington, TX
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
ARLINGTON RESEARCH CENTER, INC, 711 East Lamar Blvd
mi
from
Arlington, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
DERMRESEARCH INC., 8140 North Mopac Expressway
mi
from
Austin, TX
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
DERMRESEARCH INC., 8140 North Mopac Expressway
mi
from
Austin, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
J&S STUDIES, INC, 1710 Crescent Pointe Pkwy
mi
from
College Station, TX
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
J&S STUDIES, INC, 1710 Crescent Pointe Pkwy
mi
from
College Station, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
SUZANNE BRUCE AND ASSOCIATES, PA, 1900 St. James Place
mi
from
Houston, TX
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
SUZANNE BRUCE AND ASSOCIATES, PA, 1900 St. James Place
mi
from
Houston, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
CLINICAL TRIALS OF TEXAS, INC, 7940 Floyd Curl Drive
mi
from
San Antonio, TX
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
CLINICAL TRIALS OF TEXAS, INC, 7940 Floyd Curl Drive
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
DERMATOLOGY CLINICAL RESEARCH CENTER OF SAN ANTONIO, 7810 Louis Pasteur
mi
from
San Antonio, TX
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
DERMATOLOGY CLINICAL RESEARCH CENTER OF SAN ANTONIO, 7810 Louis Pasteur
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
CENTER FOR CLINICAL STUDIES, 451 North Texas Avenue
mi
from
Webster, TX
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
CENTER FOR CLINICAL STUDIES, 451 North Texas Avenue
mi
from
Webster, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
CHARLOTTESVILLE DERMATOLOGY, 600 Peter Jefferson Parkway
mi
from
Charlottesville, VA
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
CHARLOTTESVILLE DERMATOLOGY, 600 Peter Jefferson Parkway
mi
from
Charlottesville, VA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
INSTITUTE FOR SKIN ADVANCEMENT, 4935 40th Avenue Nw
mi
from
Calgary,
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
INSTITUTE FOR SKIN ADVANCEMENT, 4935 40th Avenue Nw
mi
from
Calgary,
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
BURKE PHARMACEUTICAL RESEARCH, 601 W. Commerce
mi
from
Bryant, AR
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
BURKE PHARMACEUTICAL RESEARCH, 601 W. Commerce
mi
from
Bryant, AR
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
ENCINO RESEARCH CENTER, 16133 Ventura Blvd
mi
from
Encino, CA
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
ENCINO RESEARCH CENTER, 16133 Ventura Blvd
mi
from
Encino, CA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
PARISH DERMATOLOGY, INC, 1845 Walnut Street
mi
from
Philadelphia, PA
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
PARISH DERMATOLOGY, INC, 1845 Walnut Street
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
CENTER FOR CLINICAL STUDIES (CCS), 1401 Binz
mi
from
Houston, TX
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
CENTER FOR CLINICAL STUDIES (CCS), 1401 Binz
mi
from
Houston, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
Burke Pharmaceutical Research
mi
from
Hot Springs, AR
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
Burke Pharmaceutical Research
mi
from
Hot Springs, AR
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
Petrus Center for Aesthetic Surgery & Hair Transplantation
mi
from
Little Rock, AR
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
Petrus Center for Aesthetic Surgery & Hair Transplantation
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
Therapeutics Clinical Research
mi
from
San Diego, CA
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
Therapeutics Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
Minnesota Clinical Study Center
mi
from
Fridley, MN
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
Minnesota Clinical Study Center
mi
from
Fridley, MN
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
NW Dermatology & Research Center, LLC
mi
from
Portland, OR
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
NW Dermatology & Research Center, LLC
mi
from
Portland, OR
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
Oregon Medical Research Center, PC
mi
from
Portland, OR
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
Oregon Medical Research Center, PC
mi
from
Portland, OR
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
DermResearch, Inc.
mi
from
Austin, TX
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
DermResearch, Inc.
mi
from
Austin, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
Suzzane Bruce and Associates P.A., The Center for Skin Research
mi
from
Katy, TX
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
Suzzane Bruce and Associates P.A., The Center for Skin Research
mi
from
Katy, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
The Education and Research Foundation, Inc.
mi
from
Lynchburg, VA
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
The Education and Research Foundation, Inc.
mi
from
Lynchburg, VA
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
Heartland Research Associates, LLC
mi
from
Wichita, KA
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
Heartland Research Associates, LLC
mi
from
Wichita, KA
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
Michigan Center for Skin Care Research
mi
from
Clinton Township, MI
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
Michigan Center for Skin Care Research
mi
from
Clinton Township, MI
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
Radiant Research
mi
from
Santa Rosa, CA
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
Radiant Research
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
DeNova Research
mi
from
Chicago, IL
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
DeNova Research
mi
from
Chicago, IL
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
University of Minnesota Department of Dermatology Division of Clinical research
mi
from
Minneapolis, MN
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
University of Minnesota Department of Dermatology Division of Clinical research
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Health Sciences Department of Dermatology Medical Center Boulevard
mi
from
Winston-Salem, NC
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Health Sciences Department of Dermatology Medical Center Boulevard
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic, Dept of Dermatology
mi
from
Cleveland, OH
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic, Dept of Dermatology
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
Penn State Hershey Medical Center Dermatology Research Office
mi
from
Hershey, PA
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
Penn State Hershey Medical Center Dermatology Research Office
mi
from
Hershey, PA
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
Radiant Research
mi
from
Greer, SC
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
Radiant Research
mi
from
Greer, SC
Click here to add this to my saved trials
Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis Patients
A Randomised, Double-blind, Placebo-controlled, Phase 2b Study to Assess the Efficacy and Safety of Orally Administered DS107 in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
DS Biopharma Site
mi
from
Philadelphia, PA
Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis Patients
A Randomised, Double-blind, Placebo-controlled, Phase 2b Study to Assess the Efficacy and Safety of Orally Administered DS107 in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
DS Biopharma Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis Patients
A Randomised, Double-blind, Placebo-controlled, Phase 2b Study to Assess the Efficacy and Safety of Orally Administered DS107 in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
DS Biopharma Site
mi
from
Cape Town,
Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis Patients
A Randomised, Double-blind, Placebo-controlled, Phase 2b Study to Assess the Efficacy and Safety of Orally Administered DS107 in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
DS Biopharma Site
mi
from
Cape Town,
Click here to add this to my saved trials
Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel
An Open Label Study to Document the Treatment Effect of 1 and 2% BPX-01 Minocycline Topical Gel in Moderate to Severe Inflammatory Non-nodular Acne Vulgaris (Protocol Number BPX-01-C04)
Status: Enrolling
Updated:  12/31/1969
Study Center
mi
from
Coral Gables, FL
Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel
An Open Label Study to Document the Treatment Effect of 1 and 2% BPX-01 Minocycline Topical Gel in Moderate to Severe Inflammatory Non-nodular Acne Vulgaris (Protocol Number BPX-01-C04)
Status: Enrolling
Updated: 12/31/1969
Study Center
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel
An Open Label Study to Document the Treatment Effect of 1 and 2% BPX-01 Minocycline Topical Gel in Moderate to Severe Inflammatory Non-nodular Acne Vulgaris (Protocol Number BPX-01-C04)
Status: Enrolling
Updated:  12/31/1969
Study Center
mi
from
Las Vegas, NV
Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel
An Open Label Study to Document the Treatment Effect of 1 and 2% BPX-01 Minocycline Topical Gel in Moderate to Severe Inflammatory Non-nodular Acne Vulgaris (Protocol Number BPX-01-C04)
Status: Enrolling
Updated: 12/31/1969
Study Center
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis
Study 205050: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Mepolizumab Administered Subcutaneously in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Sandy Springs, GA
Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis
Study 205050: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Mepolizumab Administered Subcutaneously in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Sandy Springs, GA
Click here to add this to my saved trials
Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis
Study 205050: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Mepolizumab Administered Subcutaneously in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Fremont, CA
Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis
Study 205050: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Mepolizumab Administered Subcutaneously in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Fremont, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis
Study 205050: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Mepolizumab Administered Subcutaneously in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Santa Ana, CA
Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis
Study 205050: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Mepolizumab Administered Subcutaneously in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis
Study 205050: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Mepolizumab Administered Subcutaneously in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Louisville, KY
Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis
Study 205050: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Mepolizumab Administered Subcutaneously in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Louisville, KY
Click here to add this to my saved trials
Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis
Study 205050: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Mepolizumab Administered Subcutaneously in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Portland, OR
Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis
Study 205050: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Mepolizumab Administered Subcutaneously in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials